REVB
Revelation Biosciences
$3.75
+$0.03 (+0.81%)Oct 29, 2026
Key metrics
The numbers that frame REVB today
- Market cap
- $2.13M
- ROIC
- 2,230.4%
- Div yield
- 0%
- Debt / equity
- 0.1
- 52wk Low
- $3.08
- 52wk High
- $40.60
Growth
Revenue and earnings trend for REVB
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about REVB
Is Revelation Biosciences a good buy?
No. Revelation Biosciences has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup.
What is the market capitalization of REVB?
Revelation Biosciences's market capitalization is $2.13M.
What is the 52-week high for REVB stock?
The 52-week high for Revelation Biosciences is $40.60. The current close of $3.75 is 90.8% below that high.
What is the 52-week low for REVB stock?
The 52-week low for Revelation Biosciences is $3.08. The current close of $3.75 is 21.8% above that low.
Does REVB stock pay dividends?
Revelation Biosciences does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for REVB?
Revelation Biosciences's Debt / Equity ratio is 0.07.